In 2021, the European Association of Urology and the European Commission issued a new position paper on PSA screening and the role of MRI.48 Europe’s Beating Cancer Plan proposes that the EU Council changes its recommendation on cancer screening to include population-based screening for prostate cancer (both PSA testing and MRI). The gene discussed is KLK3; the disease is cancer.